vs
Side-by-side financial comparison of STEM, INC. (STEM) and Zevia PBC (ZVIA). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $37.9M, roughly 1.2× Zevia PBC). Zevia PBC runs the higher net margin — -3.4% vs -33.9%, a 30.5% gap on every dollar of revenue. On growth, Zevia PBC posted the faster year-over-year revenue change (-4.0% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -1.2%).
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
Zevia is a Los Angeles based company that produces soft drinks, organic tea, energy drinks, and mixers sweetened with stevia. All Zevia products are zero-calorie, sugar-free, gluten free, vegan, certified kosher, and certified by The Non-GMO Project. In June 2021, Zevia filed to go public with an IPO.
STEM vs ZVIA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.1M | $37.9M |
| Net Profit | $-16.0M | $-1.3M |
| Gross Margin | 48.9% | 47.7% |
| Operating Margin | -17.7% | -4.0% |
| Net Margin | -33.9% | -3.4% |
| Revenue YoY | -15.6% | -4.0% |
| Net Profit YoY | 68.8% | 80.9% |
| EPS (diluted) | $-4.40 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.1M | $37.9M | ||
| Q3 25 | $38.2M | $40.8M | ||
| Q2 25 | $38.4M | $44.5M | ||
| Q1 25 | $32.5M | $38.0M | ||
| Q4 24 | $55.8M | $39.5M | ||
| Q3 24 | $29.3M | $36.4M | ||
| Q2 24 | $34.0M | $40.4M | ||
| Q1 24 | $25.5M | $38.8M |
| Q4 25 | $-16.0M | $-1.3M | ||
| Q3 25 | $-23.8M | $-2.7M | ||
| Q2 25 | $202.5M | $-651.0K | ||
| Q1 25 | $-25.0M | $-6.4M | ||
| Q4 24 | $-51.1M | $-6.8M | ||
| Q3 24 | $-148.3M | $-2.5M | ||
| Q2 24 | $-582.3M | $-7.0M | ||
| Q1 24 | $-72.3M | $-7.2M |
| Q4 25 | 48.9% | 47.7% | ||
| Q3 25 | 35.5% | 45.6% | ||
| Q2 25 | 33.4% | 48.7% | ||
| Q1 25 | 32.4% | 50.1% | ||
| Q4 24 | -4.4% | 49.2% | ||
| Q3 24 | 21.2% | 49.1% | ||
| Q2 24 | 27.6% | 41.9% | ||
| Q1 24 | -95.0% | 45.7% |
| Q4 25 | -17.7% | -4.0% | ||
| Q3 25 | -33.6% | -7.0% | ||
| Q2 25 | -34.8% | -2.3% | ||
| Q1 25 | -65.0% | -16.8% | ||
| Q4 24 | -84.4% | -16.1% | ||
| Q3 24 | -493.2% | -8.2% | ||
| Q2 24 | -1705.5% | -17.5% | ||
| Q1 24 | -267.0% | -18.8% |
| Q4 25 | -33.9% | -3.4% | ||
| Q3 25 | -62.2% | -6.6% | ||
| Q2 25 | 527.8% | -1.5% | ||
| Q1 25 | -76.9% | -16.8% | ||
| Q4 24 | -91.6% | -17.2% | ||
| Q3 24 | -506.3% | -6.9% | ||
| Q2 24 | -1712.6% | -17.2% | ||
| Q1 24 | -283.9% | -18.6% |
| Q4 25 | $-4.40 | $-0.02 | ||
| Q3 25 | $-2.84 | $-0.04 | ||
| Q2 25 | $-1.79 | $-0.01 | ||
| Q1 25 | $-0.15 | $-0.08 | ||
| Q4 24 | $-15.29 | $-0.10 | ||
| Q3 24 | $-18.24 | $-0.04 | ||
| Q2 24 | $-71.81 | $-0.10 | ||
| Q1 24 | $-0.46 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $48.9M | $25.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-249.4M | $51.0M |
| Total Assets | $308.9M | $63.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $48.9M | $25.4M | ||
| Q3 25 | $43.1M | $26.0M | ||
| Q2 25 | $40.8M | — | ||
| Q1 25 | $58.6M | — | ||
| Q4 24 | $56.3M | $30.7M | ||
| Q3 24 | $75.4M | — | ||
| Q2 24 | $89.6M | — | ||
| Q1 24 | $112.8M | — |
| Q4 25 | $-249.4M | $51.0M | ||
| Q3 25 | $-235.7M | $51.3M | ||
| Q2 25 | $-214.1M | $53.0M | ||
| Q1 25 | $-417.5M | $53.7M | ||
| Q4 24 | $-398.4M | $64.9M | ||
| Q3 24 | $-344.1M | $72.5M | ||
| Q2 24 | $-203.2M | $75.0M | ||
| Q1 24 | $371.6M | $80.3M |
| Q4 25 | $308.9M | $63.6M | ||
| Q3 25 | $362.6M | $60.0M | ||
| Q2 25 | $379.2M | $62.5M | ||
| Q1 25 | $405.1M | $62.0M | ||
| Q4 24 | $437.4M | $68.0M | ||
| Q3 24 | $537.8M | $72.9M | ||
| Q2 24 | $691.5M | $72.8M | ||
| Q1 24 | $1.3B | $85.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-507.0K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $-507.0K | ||
| Q3 25 | $11.4M | $116.0K | ||
| Q2 25 | $-21.3M | $-1.4M | ||
| Q1 25 | $8.5M | $-2.9M | ||
| Q4 24 | $-14.7M | $-2.0M | ||
| Q3 24 | $-9.4M | $3.9M | ||
| Q2 24 | $-11.9M | $282.0K | ||
| Q1 24 | $-621.0K | $-3.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.11× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
